Torture & Refugee Health: A Longitudinal Study of Syrian Refugees in Norway

Torture & Refugee Health: A Longitudinal Study of Syrian Refugees in Norway

The profound and lasting health consequences of torture are the focus of a new longitudinal study examining Syrian refugees resettled in Norway. Researchers are leveraging the country’s comprehensive healthcare registry data to gain a deeper understanding of how past trauma impacts long-term healthcare utilization and overall well-being. This research is particularly vital given the documented … Read more

Polygenic Risk Score for Parkinson’s Disease in a South African Cohort

Torture & Refugee Health: A Longitudinal Study of Syrian Refugees in Norway

Cape Town, South Africa – A new study is offering a crucial step forward in understanding Parkinson’s disease (PD) risk, particularly within historically underrepresented populations. Researchers have, for the first time, evaluated the performance of polygenic risk scores (PRSs) – a tool for estimating an individual’s genetic predisposition to a disease – in a highly … Read more

Magnetofluid LAAO: Personalized, Thrombus-Free Left Atrial Appendage Occlusion

Torture & Refugee Health: A Longitudinal Study of Syrian Refugees in Norway

Innovative Approach to Left Atrial Appendage Occlusion Researchers have introduced a groundbreaking method for long-term thrombus-free left atrial appendage occlusion (LAAO) utilizing magnetofluids. This new technique addresses significant challenges faced by current LAAO methods, primarily peri-device leaks and device-related thrombus, which arise from the incompatibility between traditional solid occluders and the left atrial appendage (LAA). … Read more

VV116 Pharmacokinetics & Safety in Mild/Moderate Hepatic Impairment – COVID-19 Treatment

Torture & Refugee Health: A Longitudinal Study of Syrian Refugees in Norway

The ongoing search for effective oral treatments for COVID-19 has yielded promising results for VV116 (Mindvy, JT001), a deuterated oral derivative of remdesivir hydrobromide. A recent Phase 1 study investigated how well the drug is processed by the body – its pharmacokinetics – and its safety profile in individuals with varying degrees of liver function. … Read more